Disease Awareness and Treatment Preferences in Vitiligo: A Cross-sectional Study in China
DOI:
https://doi.org/10.2340/actadv.v103.11643Keywords:
awareness, quality of life, treatment preference, vitiligo, willingness to payAbstract
In China, there is a lack of data regarding the awareness and treatment preferences among patients with vitiligo and their families. To address this gap, a cross-sectional questionnaire-based study was conducted to investigate disease awareness and treatment preferences in Chinese patients with vitiligo. The study also evaluated willingness to pay, using 2 standardized items, and assessed quality of life, using the Dermatology Life Quality Index (DLQI) score. Data from 307 patients with vitiligo (59.3% women, mean age 28.98 years, range 2–73 years) were analysed. Of these patients, 44.7% had insufficient knowledge of vitiligo, particularly those from rural areas or with low levels of education. Mean DLQI total score was 4.86 (5.24 for women and 4.30 for men). Among the most accepted treatments were topical drugs, phototherapy, and systemic therapy. Patients were relatively conservative about the duration and cost of treatment, with only 27.7% willing to pay more than 10,000 Chinese yuan renminbi (CNY) for complete disease remission. High level of education, high income, skin lesions in specific areas, and skin transplantation therapy predicted higher willingness to pay. Insufficient knowledge was associated with a higher burden of disease. In order to reduce the disease burden and improve treatment adherence it is crucial to enhance disease awareness and take into account patient preferences.
Downloads
References
Wang X, Du J, Wang T, Zhou C, Shen Y, Ding X, et al. Prevalence and clinical profile of vitiligo in China: a community-based study in six cities. Acta Derm Venereol 2013; 93: 62-65.
https://doi.org/10.2340/00015555-1397 DOI: https://doi.org/10.2340/00015555-1397
Wang Y, Li S, Li C. Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo. Clin Rev Allergy Immunol 2021; 61: 299-323.
https://doi.org/10.1007/s12016-021-08868-z DOI: https://doi.org/10.1007/s12016-021-08868-z
Osinubi O, Grainge MJ, Hong L, Ahmed A, Batchelor JM, Grindlay D, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol 2018; 178: 863-878.
https://doi.org/10.1111/bjd.16049 DOI: https://doi.org/10.1111/bjd.16049
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet 2015; 386: 74-84.
https://doi.org/10.1016/S0140-6736(14)60763-7 DOI: https://doi.org/10.1016/S0140-6736(14)60763-7
Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 2011; 65: 473-491.
https://doi.org/10.1016/j.jaad.2010.11.061 DOI: https://doi.org/10.1016/j.jaad.2010.11.061
Do Bú EA, Santos VMD, Lima KS, Pereira CR, Alexandre MES, Bezerra V. Neuroticism, stress, and rumination in anxiety and depression of people with vitiligo: an explanatory model. Acta Psychol (Amst) 2022; 227: 103613.
https://doi.org/10.1016/j.actpsy.2022.103613 DOI: https://doi.org/10.1016/j.actpsy.2022.103613
Ezzedine K, Eleftheriadou V, Jones H, Bibeau K, Kuo FI, Sturm D, et al. Psychosocial effects of vitiligo: a systematic literature review. Am J Clin Dermatol 2021; 22: 757-774.
https://doi.org/10.1007/s40257-021-00631-6 DOI: https://doi.org/10.1007/s40257-021-00631-6
Yip W, Fu H, Chen AT, Zhai T, Jian W, Xu R, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet 2019; 394: 1192-1204.
https://doi.org/10.1016/S0140-6736(19)32136-1 DOI: https://doi.org/10.1016/S0140-6736(19)32136-1
Sun J, Hu G, Ma J, Chen Y, Wu L, Liu Q, et al. Consumer satisfaction with tertiary healthcare in China: findings from the 2015 China National Patient Survey. Int J Qual Health Care 2017; 29: 213-221.
https://doi.org/10.1093/intqhc/mzw160 DOI: https://doi.org/10.1093/intqhc/mzw160
Yang TT, Lee CH, Lan CE. Impact of vitiligo on life quality of patients: assessment of currently available tools. Int J Environ Res Public Health 2022; 19: 14943.
https://doi.org/10.3390/ijerph192214943 DOI: https://doi.org/10.3390/ijerph192214943
Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989; 14: 194-198.
https://doi.org/10.1111/j.1365-2230.1989.tb00930.x DOI: https://doi.org/10.1111/j.1365-2230.1989.tb00930.x
Schmitt J, Meurer M, Klon M, Frick KD. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol 2008; 158: 351-359.
https://doi.org/10.1111/j.1365-2133.2007.08354.x DOI: https://doi.org/10.1111/j.1365-2133.2007.08354.x
Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol 2009; 161: 134-139.
https://doi.org/10.1111/j.1365-2133.2009.09091.x DOI: https://doi.org/10.1111/j.1365-2133.2009.09091.x
Elbuluk N, Ezzedine K. Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients. Dermatol Clin 2017; 35: 117-128.
https://doi.org/10.1016/j.det.2016.11.002 DOI: https://doi.org/10.1016/j.det.2016.11.002
Pun J, Randhawa A, Kumar A, Williams V. The impact of vitiligo on quality of life and psychosocial well-being in a Nepalese population. Dermatol Clin 2021; 39: 117-127.
https://doi.org/10.1016/j.det.2020.08.011 DOI: https://doi.org/10.1016/j.det.2020.08.011
Tsadik AG, Teklemedhin MZ, Mehari Atey T, Gidey MT, Desta DM. Public knowledge and attitudes towards vitiligo: a survey in Mekelle City, Northern Ethiopia. Dermatol Res Pract 2020; 2020: 3495165.
https://doi.org/10.1155/2020/3495165 DOI: https://doi.org/10.1155/2020/3495165
Juntongjin P, Abouelsaad S, Sugkraroek S, Taechakraichana N, Lungchukiet P, Nuallaong W. Awareness of vitiligo among multi-ethnic populations. J Cosmet Dermatol 2022; 21: 5922-5930.
https://doi.org/10.1111/jocd.15211 DOI: https://doi.org/10.1111/jocd.15211
Gudmundsdóttir SL, Ballarini T, Ámundadóttir ML, Mészáros J, Eysteinsdóttir JH, Thorleifsdóttir RH, et al. Clinical efficacy of a digital intervention for patients with atopic dermatitis: a prospective single-center study. Dermatol Ther (Heidelb) 2022; 12: 2601-2611.
https://doi.org/10.1007/s13555-022-00821-y DOI: https://doi.org/10.1007/s13555-022-00821-y
Tsentemeidou A, Sotiriou E, Ioannides D, Vakirlis E. Hidradenitis suppurativa-related expenditure, a call for awareness: systematic review of literature. J Dtsch Dermatol Ges 2022; 20: 1061-1072.
https://doi.org/10.1111/ddg.14796 DOI: https://doi.org/10.1111/ddg.14796
Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005; 152: 1165-1172.
https://doi.org/10.1111/j.1365-2133.2005.06456.x DOI: https://doi.org/10.1111/j.1365-2133.2005.06456.x
Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004; 9: 169-180.
https://doi.org/10.1111/j.1087-0024.2004.09113.x DOI: https://doi.org/10.1111/j.1087-0024.2004.09113.x
Ju HJ, Bae JM, Lee RW, Kim SH, Parsad D, Pourang A, et al. Surgical interventions for patients with vitiligo: a systematic review and meta-analysis. JAMA Dermatol 2021; 157: 307-316.
https://doi.org/10.1001/jamadermatol.2020.5756 DOI: https://doi.org/10.1001/jamadermatol.2020.5756
Gao PR, Wang CH, Lin YJ, Huang YH, Chang YC, Chung WH, et al. A comparative study of suction blister epidermal grafting and automated blister epidermal micrograft in stable vitiligo. Sci Rep 2022; 12: 393.
https://doi.org/10.1038/s41598-021-04299-0 DOI: https://doi.org/10.1038/s41598-021-04299-0
Mrigpuri S, Razmi TM, Sendhil Kumaran M, Vinay K, Srivastava N, Parsad D. Four compartment method as an efficacious and simplified technique for autologous non-cultured epidermal cell suspension preparation in vitiligo surgery: a randomized, active-controlled study. J Eur Acad Dermatol Venereol 2019; 33: 185-190.
https://doi.org/10.1111/jdv.15234 DOI: https://doi.org/10.1111/jdv.15234
Zhou H, You C, Wang X, Jin R, Wu P, Li Q, et al. The progress and challenges for dermal regeneration in tissue engineering. J Biomed Mater Res A 2017; 105: 1208-1218.
https://doi.org/10.1002/jbm.a.35996 DOI: https://doi.org/10.1002/jbm.a.35996
Beikert FC, Langenbruch AK, Radtke MA, Augustin M. Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol 2013; 27: 734-738.
https://doi.org/10.1111/j.1468-3083.2012.04549.x DOI: https://doi.org/10.1111/j.1468-3083.2012.04549.x
Downloads
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Xiaolin Zhang, Adnan Falak Naz, Ling Jiang, Chuhan Fu, Jinhua Huang, Yixuan Liang, Lu Zhu, Fan Zhang, Jing Chen, Li Lei, Qinghai Zeng
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
Funding data
-
National Natural Science Foundation of China
Grant numbers No. 82103704 -
Natural Science Foundation of Hunan Province
Grant numbers No. 2021JJ20089